November 30, 2012

A new report shows that drug makers lose nearly $200 billion per year from medication nonadherence, illustrating that it's not just the healthcare system overall that loses when people don't take their medications properly.

This just goes to show the important role that pharmacy retailers have in helping to promote medication adherence by having pharmacists play an active role in patients' health care through services like medication therapy management.

November 29, 2012

Just how much of an impact the loss of patent protection can have on a blockbuster drug became clear earlier this year.


November 29, 2012

The Food and Drug Administration approved a new generic drug made by Mylan for urinary disorders, the company said Thursday.

November 29, 2012

A Food and Drug Administration panel has voted to recommend approval for a Johnson & Johnson drug to treat tuberculosis while the agency has recommended accelerated approval for the drug, the company said.

November 29, 2012

Patent settlements between generic and branded drug companies seem like one of the most controversial and long-standing issues in the pharmaceutical world, with strong opinions on both sides.


November 29, 2012

The National Community Pharmacists Association on Wednesday released Moving Forward on a Solid Foundation: Year One Progress Report, which examines the success of the association's strategic initiative Pharmacists Advancing Medication Adherence.

November 29, 2012

Watson Pharmaceuticals is changing its name to Actavis following its acquisition of the Swiss drug maker, Watson said.

November 29, 2012

Ultimately, there’s no “retail pharmacy” without the “pharmacy,” and that’s true of any store that dispenses prescription drugs — whether it’s a small independent drug store, a nationwide chain, a supermarket or a mass merchandiser. But in many respects, Rite Aid is trying to make the “pharmacy” component of that phrase just a little bit bigger.


November 29, 2012

In 2011 and 2012, the steady surge of blockbuster pharmaceuticals falling off the patent cliff became a stampede. An astonishing number of big-selling drugs that had established and sustained branded drug makers’ profits for years fell victim to the expiration of their patent lives and market exclusivity, roiling the pharmaceutical marketplace and redefining the pricing model for many of the most widely prescribed classes of medicines.


November 29, 2012

MediSafe Project has launched what it called the first cloud-synced mobile app to help prevent emergencies caused by over- or under-dosing medications. 


November 29, 2012

Valeant Consumer Products recently announced that its line of Ocean Saline Nasal Sprays have been the most recommended by pharmacists for 15 years running. 


November 29, 2012

The global market for generic drugs will reach more than $125 billion next year, according to a new report by a British market-research firm.

November 29, 2012

Generic Pharmaceutical Association president and CEO Ralph Neas called it “the most important pharmaceutical legislation since the 1984 Hatch-Waxman Act.” John Castellani, president and CEO of the Pharmaceutical Research and Manufacturers of America, said the law served “the best interests of America’s patients.”


November 28, 2012

The November/December 2012 Cough, Cold and Flu Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Mucinex, Vicks, Advil, Theraflu, Delsym, St. Joseph, Hyland's Similasan and Zicam products.

November 28, 2012

Some legislators are concerned with the way energy drinks can affect young consumers.

November 28, 2012

The Food and Drug Administration has approved a drug from Perrigo and Cobrek Pharmaceuticals for treating scalp conditions.

November 28, 2012

Physicians Interactive and McKesson Patient Relationship Solutions on Tuesday announced a joint collaboration to deliver eCoupon, one of the industry’s first automated pharmaceutical voucher and coupon distribution solution for clinicians who use electronic health records and ePrescribing software.

November 28, 2012

The Food and Drug Administration will review the safety of energy drinks containing such stimulants as caffeine in response to a letter from two senators.

November 28, 2012

Smart Insurance on Wednesday announced it is working with Walgreens to offer in-store consultations with licensed SmartD Rx plan agents, available at select Walgreens to speak with Medicare beneficiaries who are either enrolling in a new Part D prescription drug plan or evaluating their current coverage options.

November 28, 2012

Here’s a shocking statistic: half of the roughly 4 billion prescriptions dispensed by U.S. pharmacies are not taken as prescribed, according to The New England Journal of Medicine, which blames the problem for 33% to 69% of all medication-related hospital admissions.

November 28, 2012

Price inflation for the most commonly used branded drugs has been more than six times that of overall inflation for consumer goods since September 2011, according to a new report by pharmacy benefit manager Express Scripts.

November 27, 2012

Automated phone and mail reminders increase the likelihood that patients with new prescriptions for cholesterol-lowering drugs will pick them up from the pharmacy, according to a new study.

November 27, 2012

Ranbaxy Labs has recalled more than three dozen lots of its generic version of a cholesterol-lowering statin drug due to the possible presence of foreign particles, the company said.

November 27, 2012

Indian generic drug maker Wockhardt received three new drug approvals from the Food and Drug Administration, agency records show.